Targeted treatments for multiple myeloma: specific role of carfilzomib

por Sugumar, Dhivya, Keller, Jesse, Vij, Ravi
Publicado 2015

Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study

por Mian, Hira, Wildes, Tanya M., Vij, Ravi, Pianko, Matthew J., Major, Ajay, Fiala, Mark A.
Publicado 2023

Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study

por Cella, David, McKendrick, Jan, Kudlac, Amber, Palumbo, Antonio, Oukessou, Abderrahim, Vij, Ravi, Zyczynski, Teresa, Davis, Catherine
Publicado 2018

Germinal Center B-Cells Resist Transformation by Kras Independently of Tumor Suppressor Arf

por Mullins, Chelsea D., Su, Mack Y., Hucthagowder, Vishwanathan, Chu, Liang, Lu, Lan, Kulkarni, Shashikant, Novack, Deborah, Vij, Ravi, Tomasson, Michael H.
Publicado 2013

High dose therapy and autologous stem cell transplant in older adults with multiple myeloma

por Wildes, Tanya M, Finney, Joseph D, Fiala, Mark, Gao, Feng, Vij, Ravi, Stockerl-Goldstein, Keith, Carson, Kenneth R, Mikhael, Joseph, Colditz, Graham
Publicado 2015

Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy

por Muz, Barbara, Azab, Feda, Fiala, Mark, King, Justin, Kohnen, Daniel, Fogler, William E., Smith, Ted, Magnani, John L., Vij, Ravi, Azab, Abdel Kareem
Publicado 2019

Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase...

por Berdeja, Jesus, Jagannath, Sundar, Zonder, Jeffrey, Badros, Ashraf, Kaufman, Jonathan L., Manges, Robert, Gupta, Manish, Tendolkar, Amol, Lynch, Mark, Bleickardt, Eric, Paliwal, Prashni, Vij, Ravi
Publicado 2015

Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM

por Wong, Sandy, Hamidi, Habib, Costa, Luciano J., Bekri, Selma, Neparidze, Natalia, Vij, Ravi, Nielsen, Tina G., Raval, Aparna, Sareen, Rajan, Wassner-Fritsch, Elisabeth, Cho, Hearn J.
Publicado 2023

A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myeloma

por Alhallak, Kinan, Jeske, Amanda, de la Puente, Pilar, Sun, Jennifer, Fiala, Mark, Azab, Feda, Muz, Barbara, Sahin, Ilyas, Vij, Ravi, DiPersio, John F., Azab, Abdel Kareem
Publicado 2021

Nanoparticle T-cell engagers as a modular platform for cancer immunotherapy

por Alhallak, Kinan, Sun, Jennifer, Wasden, Katherine, Guenthner, Nicole, O’Neal, Julie, Muz, Barbara, King, Justin, Kohnen, Daniel, Vij, Ravi, Achilefu, Samuel, DiPersio, John F., Azab, Abdel Kareem
Publicado 2021

P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY

por Ramasamy, Karthik, Goldschmidt, Hartmut, Moreau, Philippe, Petrucci, Maria-Teresa, Kuter, David, Durie, Brian, Cella, David, Dhanda, Devender, Gu, Jin, Amin, Suvina, Marshall, Thomas, Patwardhan, Pallavi, Fish, Susan, Vij, Ravi
Publicado 2023

Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma

por Sun, Jennifer, Muz, Barbara, Alhallak, Kinan, Markovic, Matea, Gurley, Shannon, Wang, Zhe, Guenthner, Nicole, Wasden, Katherine, Fiala, Mark, King, Justin, Kohnen, Daniel, Salama, Noha Nabil, Vij, Ravi, Azab, Abdel Kareem
Publicado 2020

Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leuke...

por Medeiros, Bruno C., McCaul, Kelly, Kambhampati, Suman, Pollyea, Daniel A., Kumar, Rajat, Silverman, Lewis R., Kew, Andrea, Saini, Lalit, Beach, CL, Vij, Ravi, Wang, Xiwei, Zhong, Jim, Gale, Robert Peter
Publicado 2018

Evolution and structure of clinically relevant gene fusions in multiple myeloma

por Foltz, Steven M., Gao, Qingsong, Yoon, Christopher J., Sun, Hua, Yao, Lijun, Li, Yize, Jayasinghe, Reyka G., Cao, Song, King, Justin, Kohnen, Daniel R., Fiala, Mark A., Ding, Li, Vij, Ravi
Publicado 2020

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival

por Hathi, Deep, Chanswangphuwana, Chantiya, Cho, Nicholas, Fontana, Francesca, Maji, Dolonchampa, Ritchey, Julie, O’Neal, Julie, Ghai, Anchal, Duncan, Kathleen, Akers, Walter J., Fiala, Mark, Vij, Ravi, DiPersio, John F., Rettig, Michael, Shokeen, Monica
Publicado 2022

PB2114: BELANTAMAB MAFODOTIN FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL-WORLD OBSERVATIONAL STUDY UPDATE

por Hultcrantz, Malin, Kleinman, David, Vij, Ravi, Escalante, Fernando, Delforge, Michel, Kotowsky, Nirali, Bitetti, Jacopo, Boytsov, Natalie, Camadoo-O’byrne, Leena, Happ, Lindsey Powers, Rohman, Mujib, Germain, Guillaume, Duh, Mei Sheng, Laliberté, François, Mahendran, Malena, Urosevic, Ana, Lee, Hans C.
Publicado 2023

Personalization of cancer treatment using predictive simulation

por Doudican, Nicole A, Kumar, Ansu, Singh, Neeraj Kumar, Nair, Prashant R, Lala, Deepak A, Basu, Kabya, Talawdekar, Anay A, Sultana, Zeba, Tiwari, Krishna Kumar, Tyagi, Anuj, Abbasi, Taher, Vali, Shireen, Vij, Ravi, Fiala, Mark, King, Justin, Perle, MaryAnn, Mazumder, Amitabha
Publicado 2015

A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma

por Mikhael, Joseph, Richter, Joshua, Vij, Ravi, Cole, Craig, Zonder, Jeffrey, Kaufman, Jonathan L., Bensinger, William, Dimopoulos, Meletios, Lendvai, Nikoletta, Hari, Parameswaran, Ocio, Enrique M., Gasparetto, Cristina, Kumar, Shaji, Oprea, Corina, Chiron, Marielle, Brillac, Claire, Charpentier, Eric, San-Miguel, Jesús, Martin, Thomas
Publicado 2020

A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma

por D'Souza, Anita, Shah, Nina, Rodriguez, Cesar, Voorhees, Peter M., Weisel, Katja, Bueno, Orlando F., Pothacamury, Rajvineeth K., Freise, Kevin J., Yue, Susan, Ross, Jeremy A., Polepally, Akshanth R., Talati, Chetasi, Lee, Shane, Jin, Ziyi, Buelow, Ben, Vij, Ravi, Kumar, Shaji
Publicado 2022

P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

por Weisel, Katja, D’souza, Anita, Hurd, David, Voorhees, Peter, Teipel, Raphael, Chung, Alfred, Rodriguez, Cesar, Tuchman, Sacha, Korde, Neha, Safah, Hana, Bueno, Orlando, Feng, Zhongling, Rosenberg, Tanya, Kumar Pothacamury, Rajvineeth, Ross, Jeremy, Lee, Shane, Jin, Ziyi, Talati, Chetasi, Kumar, Shaji, Vij, Ravi
Publicado 2023